Kala Pharmaceuticals (KALA) Announces FDA Acceptance of IND Application for KPI-012 for the Treatment of PCED streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Kala Pharmaceuticals Shares Jump Nearly 20% on News of IND, Private Placement morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
On-track to initiate Phase 2b trial in 4Q 2022, with topline data expected in 1Q 2024 Cash runway extended into 1Q 2025, pending receipt of second tranche from previously announced financing,. | November 28, 2022
Kala Pharmaceuticals (KALA) Announces Up to $31 Million Private Placement Financing streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.